Landscape Capital Management L.L.C. decreased its stake in CVS Health Corporation (NYSE:CVS – Free Report) by 88.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 9,452 shares of the pharmacy operator’s stock after selling 72,862 shares during the period. Landscape Capital Management L.L.C.’s holdings in CVS Health were worth $810,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently made changes to their positions in the stock. Composition Wealth LLC boosted its holdings in shares of CVS Health by 14.0% in the third quarter. Composition Wealth LLC now owns 8,522 shares of the pharmacy operator’s stock worth $730,000 after buying an additional 1,044 shares during the period. Voya Investment Management LLC increased its position in shares of CVS Health by 6.4% in the third quarter. Voya Investment Management LLC now owns 463,422 shares of the pharmacy operator’s stock worth $39,711,000 after acquiring an additional 27,717 shares in the last quarter. Global Retirement Partners LLC raised its holdings in shares of CVS Health by 8.1% during the third quarter. Global Retirement Partners LLC now owns 29,524 shares of the pharmacy operator’s stock valued at $2,530,000 after acquiring an additional 2,215 shares during the period. BCGM Wealth Management LLC raised its holdings in shares of CVS Health by 5.0% during the third quarter. BCGM Wealth Management LLC now owns 32,147 shares of the pharmacy operator’s stock valued at $2,755,000 after acquiring an additional 1,535 shares during the period. Finally, Garrison Point Advisors LLC lifted its position in shares of CVS Health by 5.4% in the 3rd quarter. Garrison Point Advisors LLC now owns 9,699 shares of the pharmacy operator’s stock valued at $831,000 after acquiring an additional 499 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.
CVS Health Trading Up 1.0%
Shares of NYSE:CVS opened at $80.83 on Friday. The firm has a fifty day moving average of $88.42 and a two-hundred day moving average of $89.29. The firm has a market capitalization of $103.42 billion, a P/E ratio of 9.41, a price-to-earnings-growth ratio of 0.77 and a beta of 0.58. CVS Health Corporation has a 12-month low of $69.51 and a 12-month high of $110.68. The company has a quick ratio of 0.66, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The business had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. During the same period in the previous year, the company posted $1.60 EPS. CVS Health’s revenue was up 5.4% on a year-over-year basis. On average, equities analysts expect that CVS Health Corporation will post 8.26 EPS for the current fiscal year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were given a $0.6650 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health’s dividend payout ratio is presently 30.97%.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on CVS shares. JPMorgan Chase & Co. raised their price objective on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Wells Fargo & Company cut their target price on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating on the stock in a research note on Thursday, November 12th. Leerink Partners reduced their target price on CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a report on Thursday, November 5th. Argus upped their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Finally, Wall Street Zen downgraded CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 19th. Twenty-three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $107.33.
View Our Latest Stock Report on CVS
Insiders Place Their Bets
In other news, EVP Prem Shah purchased 23,855 shares of CVS Health stock in a transaction dated Friday, November 6th. The stock was acquired at an average cost of $83.89 per share, for a total transaction of $2,001,195.95. Following the acquisition, the executive vice president directly owned 88,516 shares in the company, valued at $7,425,607.24. This represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.85% of the stock is currently owned by insiders.
Latest CVS Health News
These are some of the CVS news items that stood out recently:
- Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
- Neutral Sentiment: CVS also announced winners of a youth soccer contest, with grants for their nonprofit organizations. This is brand and community outreach rather than a material financial catalyst. Article: CVS Pharmacy names Home Team Heroes contest winners
- Negative Sentiment: A local pharmacist activist said the upcoming CVS split would not benefit patients or workers. This reflects criticism of the plan, but the report does not establish broader opposition or quantify any financial impact. Article: Pharmacist activist criticizes upcoming CVS split
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Recommended Stories
- Five stocks we like better than CVS Health
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
